Intraperitoneal administration of ML141 partially attenuated the hypoglycemic phenotype during OGTTs, although this effect did not reach statistical significance ( Figure 16 F ).
← all excerpts
DOCK10 Regulates Insulin Hypersecretion in Insulinoma and Serves as a Diagnostic and Therapeutic Target.
1
—
—